Literature DB >> 3460525

Degradation kinetics of imipenem in normal saline and in human serum.

D J Swanson, C DeAngelis, I L Smith, J J Schentag.   

Abstract

The stability of imipenem in 0.9% sodium chloride and in human serum was measured at controlled temperatures over time. The degradation was characterized by a first-order process and was consistent with an apparent hydrolysis reaction.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3460525      PMCID： PMC284186          DOI： 10.1128/AAC.29.5.936

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Multiple-dose pharmacokinetics of imipenem-cilastatin.

Authors:  G L Drusano; H C Standiford; C Bustamante; A Forrest; G Rivera; J Leslie; B Tatem; D Delaportas; R R MacGregor; S C Schimpff
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

2.  Determination of imipenem (N-formimidoyl thienamycin) in human plasma and urine by high-performance liquid chromatography, comparison with microbiological methodology and stability.

Authors:  D A Gravallese; D G Musson; L T Pauliukonis; W F Bayne
Journal:  J Chromatogr       Date:  1984-09-14

3.  Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.

Authors:  S R Norrby; K Alestig; F Ferber; J L Huber; K H Jones; F M Kahan; M A Meisinger; J D Rogers
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

4.  Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors.

Authors:  S R Norrby; K Alestig; B Björnegård; L A Burman; F Ferber; J L Huber; K H Jones; F M Kahan; J S Kahan; H Kropp; M A Meisinger; J G Sundelof
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

5.  Bioactivity of imipenem as a function of medium, time, and temperature.

Authors:  E J Baron; J A Hindler
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

6.  Disposition of radiolabeled imipenem and cilastatin in normal human volunteers.

Authors:  S R Norrby; J D Rogers; F Ferber; K H Jones; A G Zacchei; L L Weidner; J L Demetriades; D A Gravallese; J Y Hsieh
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

7.  Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography.

Authors:  C M Myers; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

8.  MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.

Authors:  H Kropp; J G Sundelof; J S Kahan; F M Kahan; J Birnbaum
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

9.  In vitro activity of N-formimidoyl thienamycin (MK0787).

Authors:  F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

10.  Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.

Authors:  H Kropp; J G Sundelof; R Hajdu; F M Kahan
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191
  10 in total
  10 in total

Review 1.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  Clinical pharmacology of imipenem and cilastatin in premature infants during the first week of life.

Authors:  M D Reed; R M Kliegman; T S Yamashita; C M Myers; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Comparison of MALDI-ToF MS with the Rapidec Carba NP test for the detection of carbapenemase-producing Enterobacteriaceae.

Authors:  M Choquet; R Guiheneuf; S Castelain; V Cattoir; M Auzou; E Pluquet; V Decroix
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-04       Impact factor: 3.267

4.  Determination of the amino acid sequence requirements for catalysis by the highly proficient orotidine monophosphate decarboxylase.

Authors:  Ji Yuan; Ana Maria Cardenas; Hiram F Gilbert; Timothy Palzkill
Journal:  Protein Sci       Date:  2011-09-22       Impact factor: 6.725

5.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 6.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

7.  Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels.

Authors:  R L White; M B Kays; L V Friedrich; E W Brown; J R Koonce
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

8.  Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Marie Kempf; Sofiane Bakour; Christophe Flaudrops; Meryem Berrazeg; Jean-Michel Brunel; Mourad Drissi; Esma Mesli; Abdelaziz Touati; Jean-Marc Rolain
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

9.  Influence of Concentration and Temperature on Stability of Imipenem Focused on Solutions for Extended Infusion.

Authors:  Chuleegone Sornsuvit; Purida Wientong; Suriyon Uitrakul; Siriporn Okonogi; Wasan Katip
Journal:  Dose Response       Date:  2021-11-23       Impact factor: 2.658

10.  A Natural Deep Eutectic Solvent Formulated to Stabilize β-Lactam Antibiotics.

Authors:  Belén Olivares; Fabián Martínez; Lina Rivas; Cristian Calderón; José M Munita; Paola R Campodonico
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.